Addex Therapeutics
ADXN
5 hedge funds and large institutions have $1.19M invested in Addex Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.02% more ownership
Funds ownership: 0.08% → 0.1% (+0.02%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
78% less capital invested
Capital invested by funds: $5.42M → $1.19M (-$4.23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$2.86M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$117K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$1.35M |
| 2 |
AC
Armistice Capital
New York
|
-$1.18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $1.08M | +$2.86M | +38,072 | +423% |
|
|
NLVP
2
New Leaf Venture Partners
New York
| $58K | – | – | – |
|
|
OMC
3
Old Mission Capital
Chicago,
Illinois
| $36K | +$117K | +1,557 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | +$19.4K | +258 | +184% |
|
|
AC
5
Armistice Capital
New York
| $291 | -$1.18M | -15,753 | -55% |
|
|
CC
6
Caxton Corporation
Princeton,
New Jersey
| – | -$1.35M | -13,297 | Closed |
|
ADXN Hedge Fund Activity: Q2 2022 in Review
5 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q2 2022, worth a combined $1.19M — down 78% from $5.42M a quarter earlier.
Fund positioning in ADXN was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was NEA Management Company, adding an estimated $2.86M. The largest seller was Caxton Corporation, exiting entirely with an estimated $1.35M sold.
- 5 institutional investors held Addex Therapeutics (ADXN) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.19M of Addex Therapeutics stock for Q2 2022, down 78% quarter-over-quarter.
- 1 fund opened new Addex Therapeutics positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest Addex Therapeutics buyer in Q2 2022 was NEA Management Company, an estimated $2.86M added.
- The largest Addex Therapeutics seller in Q2 2022 was Caxton Corporation, an estimated $1.35M sold.
Based on aggregated 13F filings for Q2 2022.